Brain scans reveal hidden damage in glaucoma patients
NCT ID NCT01621841
First seen Jun 13, 2026 · Last updated Jun 20, 2026 · Updated 1 time
Summary
This study uses a powerful 3-Tesla MRI to compare the visual pathways in the brains of 114 people with glaucoma against healthy volunteers of the same age and sex. The goal is to see if glaucoma causes damage beyond the eye, in the brain's visual processing areas. Researchers hope this will improve understanding of the disease and its links to other neurodegenerative conditions like Alzheimer's.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service d'ophtalmologie Hôpital Pellegrin
CHU de Bordeaux, Bordeaux, 33000, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better understand how glaucoma affects the brain's visual pathways, potentially leading to earlier detection or new treatment targets.
What could go wrong
This is an observational imaging study, not a treatment trial. It may not directly lead to new therapies, and the findings might not apply to all glaucoma patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.